Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Actinium Pharmaceuticals, Inc. (ATNM)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
4.9600+0.1500 (+3.12%)
At close: 04:00PM EDT
5.0500 +0.09 (+1.81%)
After hours: 07:57PM EDT
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Revenue
1,462
1,144
0
0
0
Operating Expense
26,218
26,108
22,393
22,071
23,827
Operating Income
-24,756
-24,964
-22,393
-22,071
-23,827
Net Non Operating Interest Income Expense
173
190
178
172.393
173.359
Pretax Income
-24,583
-24,774
-22,215
-21,899
-23,654
Net Income Common Stockholders
-24,583
-24,774
-22,216
-21,900
-23,654
Diluted NI Available to Com Stockholders
-24,583
-24,774
-22,216
-21,900
-23,654
Basic EPS
-
-1.20
-1.83
-4.50
-6.60
Diluted EPS
-
-1.20
-1.83
-4.50
-6.60
Basic Average Shares
-
20,568
12,134
4,976
3,535
Diluted Average Shares
-
20,568
12,134
4,976
3,535
Total Operating Income as Reported
-24,756
-24,964
-22,393
-22,071
-23,827
Total Expenses
26,218
26,108
22,393
22,071
23,827
Net Income from Continuing & Discontinued Operation
-24,583
-24,774
-22,215
-21,899
-23,654
Normalized Income
-24,583
-24,774
-22,215
-21,899
-23,654
Interest Income
173
190
178
172.393
173.359
Net Interest Income
173
190
178
172.393
173.359
EBIT
-24,756
-24,964
-22,393
-22,071
-23,827
EBITDA
-24,220
-
-
-
-
Reconciled Depreciation
536
524
447
420.089
50.721
Net Income from Continuing Operation Net Minority Interest
-24,583
-24,774
-22,215
-21,899
-23,654
Normalized EBITDA
-24,220
-24,440
-21,946
-21,651
-23,777
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
Advertisement
Advertisement